Pharmacokinetics of Meropenem in People with Cystic Fibrosis-A Proof of Concept Clinical Trial

• Egile Nagusiak: Jan C. Kamp (Egilea), Jan Fuge (Egilea), Felix C. Ringshausen (Egilea), Denis Grote-Koska (Egilea), Korbinian Brand (Egilea), Lukas Graalmann (Egilea), Ralf-Peter Vonberg (Egilea), Tobias Welte (Egilea), Jessica Rademacher (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Anti-infective treatment of pulmonary exacerbations is a major issue in people with cystic fibrosis (CF). Individualized dosing strategies and adaptation of infusion times are important concepts to optimize anti-infective therapy. In this prospective non-randomized controlled open-label trial, we co...